Pacific Shuanglin Bio-pharmacy Co., LTD reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 706.58 million compared to CNY 990.73 million a year ago. Revenue was CNY 709.07 million compared to CNY 991.05 million a year ago.

Net income was CNY 143.14 million compared to CNY 221.01 million a year ago. Basic earnings per share from continuing operations was CNY 0.1958 compared to CNY 0.3026 a year ago. Diluted earnings per share from continuing operations was CNY 0.1958 compared to CNY 0.3024 a year ago.